Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.

For super-resolution microscopes, AI helps by restoring images from even noisy, low-fluorescence data. That capability helps ...

While House, Senate thwarted 40% cut to agency’s budget, about half of the largest recipients of agency grants saw cuts ...

Mice lacking the extracellular matrix protein tenascin-C showed a reduced ability to repair muscular damage compared to controls.

NeuMap, the first single‑cell atlas of neutrophils, reveals conserved functional hubs across health, infection, and cancer, reshaping immunity.

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection.

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

Results provide strong support for the beneficial effects of low-dose nutrient supplement combinations, the researchers report.

EMMI leverages “the largest global database of binding data” to generate small molecule drugs in new chemical space to tackle hard targets.

Xmoor expects to gain from direct collaboration with UCL’s translational researchers, enabling it to take part in technological innovation.

TY1 enhances the action of TREX1, a gene that helps immune cells clear damaged DNA, helping to minimize scar tissue post heart attacks.